COMPLICATIONS AND OUTCOMES OF PREGNANCY IN CHRONIC KIDNEY DISEASE

Cover Page


Cite item

Full Text

Abstract

Pregnancy in women with kidney disorders, even with preserved renal function, is associated with higher than in the population rates of obstetric and perinatal complications, such as eclampsia, preterm delivery, surgical deliveries and intensive care for newborns.

This article presents our own data on complications and outcomes of pregnancies in 156 women with various stages of chronic kidney disease (CKD). From these, 87 patients had CKD stage I, 29 with CKD stage II and 40 with CKD stages III, IV, V. For the first time in Russia, the authors summarize their unique experience in management of pregnancy with CKD, underline a high probability (27,5%) of its primary detection during pregnancy, discuss the algorithms of assessment, prevention and treatment of various gestational complications in CKD (pre-eclampsia, urinary tract infections, feto-placental insufficiency, anemia, acute renal damage), as well as the influence of pregnancy on renal function at long-term post-delivery. A direct correlation between the CKD stage, frequency of pre-eclampsia, feto-placental insufficiency, preterm deliveries, surgical deliveries by caesarean section and babies’ status at birth is demonstrated.

Based on their ample clinical material, they confirmprobability of favorable pregnancy outcomes in CKD patients with stable renal function without severe arterial hypertension during pregnancy: for a baby in 87%, for the mother in 90% (maintenance of the same CKD stage). The risk of persistent deterioration of renal function during pregnancy and puerperium in women with CKD is higher in CKD stage IV, as well as in the case of early development of pre-eclampsia; it also correlates with severity of the latter.

The probability of a favorable obstetric and nephrological outcome is higher when the pregnancy is planned and intensively co-managed by an obstetrician/gynaecologist and a nephrologist from early weeks of gestation onwards.

About the authors

I. G. Nikol'skaya

Moscow Regional Research and Clinical Institute (MONIKI)

Author for correspondence.
Email: guzmoniiag@gmail.com

PhD, Scientific Secretary

Россия

E. I. Prokopenko

Moscow Regional Scientific Research Institute for Obstetrics and Gynecology

Email: fake@neicon.ru

MD, PhD, Professor, Chair of Transplantology, Nephrology and Artificial Organs, Postgraduate Training Faculty

Россия

S. V. Novikova

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Head of Observational Obstetric Department

Россия

T. S. Budykina

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

MD, PhD, Head of Clinical and Diagnostic Laboratory

Россия

S. N. Kokarovtseva

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

PhD, Senior Research Fellow, the Group on Molecular Genetics

Россия

A. A. Yakubina

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru

Junior Research Fellow, Department of Neonatology

Россия

M. S. Krupskaya

Moscow Regional Research and Clinical Institute (MONIKI)

Email: fake@neicon.ru
Research Fellow Россия

References

  1. Никольская ИГ, Новикова СВ, Баринова ИВ, Федотова АВ, Будыкина ТС, Долгиева ЛУ, Крупская МС. Хроническая болезнь почек и беременность: этиология, патогенез, классификация, клиническая картина, перинатальные осложнения. Российский вестник акушера-гинеколога. 2012;12(5):21–30. (Nikol'skaya IG, Novikova SV, Barinova IV, Fedotova AV, Budykina TS, Dolgieva LU, Krupskaya MS. [Chronic kidney disease and pregnancy: etiology, pathophysiology, classification, clinical picture and perinatal complications]. Rossiyskiy vestnik akushera-ginekologa. 2012;12(5):21–30. Russian).
  2. Никольская ИГ, Новикова СВ, Будыкина ТС, Цивцивадзе ЕБ, Микаелян АВ, Егорова НВ. Беременность при хронической почечной недостаточности: тактика ведения и родоразрешения при консервативно-курабельной стадии. Российский вестник акушера-гинеколога. 2012;12(6):21–8. (Nikol'skaya IG, Novikova SV, Budykina TS, Tsivtsivadze EB, Mikaelyan AV, Egorova NV. [Pregnancy in chronic renal failure: strategies of management and delivery at its conservatively curable stage]. Rossiyskiy vestnik akushera-ginekologa. 2012;12(6):21–8. Russian).
  3. Прокопенко ЕИ, Никольская ИГ. Беременность у женщин с хронической почечной недостаточностью. Врач. 2013;(8):9–17.
  4. (Prokopenko EI, Nikol'skaya IG. [Pregnancy in women with chronic renal failure]. Vrach. 2013;(8):9–17. Russian).
  5. Прокопенко ЕИ, Никольская ИГ, Ватазин АВ. Хроническая болезнь почек и беременность: учебное пособие. М.: У Никитских ворот; 2013. 31 c. (Prokopenko EI, Nikol'skaya IG, Vatazin AV. Chronic kidney disease and pregnancy: a textbook. Moscow: U Nikitskikh vorot; 2013. 31 p. Russian).
  6. Шрайер РВ, ред. Руководство по нефрологии. Пер. с англ. М.: ГЭОТАР-Медиа; 2009. 560 с. (Schrier RW, editor. Manual of nephrology. Moscow: GEOTAR-Media; 2009. 560 p. Russian).
  7. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.
  8. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1): 1–126.
  9. Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int. 2012;2(1 Suppl):1–26.
  10. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.
  11. Edipidis K. Pregnancy in women with renal disease. Yes or no? Hippokratia. 2011;15(Suppl 1):8–12.
  12. Pipili C, Grapsa E, Koutsobasili A, Sorvinou P, Poirazlar E, Kiosses D, Xatzigeorgiou G. Pregnancy in dialysis-dependent women – the importance of frequent dialysis and collaborative care: a case report. Hemodial Int.2011;15(3):306–11.
  13. Бибиков БТ, Томилина НА. Состояние заместительной терапии больных с хронической почечной недостаточностью в Российской Федерации в 1998–2009 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ. 2011;(3):151–248. (Bibikov BT, Tomilina NA. [Status of renal replacement therapy in patients with chronic renal failure in the Russian Federation in 1998– 2009 (the report based on data from the Russian Registry of Renal Replacement Therapy)]. Nefrologiya i dializ. 2011;(3):151–248. Russian).
  14. Нагайцева СС, Швецов МЮ, Герасимов АН, Журавлева ЕА, Шилов ЕМ. Исследование альбуминурии как маркера хронической болезни почек у взрослого трудоспособного населения. Альманах клинической медицины. 2014;30:37–45. (Nagaytseva SS, Shvetsov MYu, Gerasimov AN, Zhuravleva EA, Shilov EM. [Assessment of albumin uria as a marker of chronic kidney disease in adult capable population]. Al'manakh klinicheskoy meditsiny. 2014;30:37–45. Russian).
  15. Шилов ЕМ, Козловская НЛ, Бобкова ИН, Швецов МЮ, Ватазин АВ. Хроническая болезнь почек и программа народосбережения Российской Федерации. Клиническая нефрология. 2010;(3):29–38. (Shilov EM, Kozlovskaya NL, Bobkova IN, Shvetsov MYu, Vatazin AV. [Chronic kidney disease and the program of maintenance of the population of the Russian Federation]. Klinicheskaya nefrologiya. 2010;(3):29–38. Russian).
  16. Imbasciati E, Gregorini G, Cabiddu G, Gammaro L, Ambroso G, Del Giudice A, Ravani P. Pregnancy in CKD stages 3 to 5: fetal
  17. and maternal outcomes. Am J Kidney Dis. 2007;49(6):753–62.
  18. Piccoli GB, Attini R, Vasario E, Conijn A, Biolcati M, D'Amico F, Consiglio V, Bontempo S, Todros T. Pregnancy and chronic kidney disease: a challenge in all CKD stages. Clin J Am Soc Nephrol. 2010;5(5):844–55.
  19. Гурьева ВМ, Петрухин ВА, Бурумкулова ФФ, Холдина МА. Планирование беременности и профилактика фетоплацентарной недостаточности у женщин группы высокого риска. Вопросы гинекологии, акушерства и перинатологии. 2012;(3):77–9. (Gur'eva VM, Petrukhin VA, Burumkulova FF, Kholdina MA. [Pregnancy planning and prevention of feto-placental insufficiency in high risk women]. Voprosy ginekologii, akusherstva i perinatologii. 2012;(3):77–9. Russian).
  20. Davison JM, Lindheimer MD. Chronic renal disease. Clin Obstet Gynecol. 1984;27(4): 891–901.
  21. Fischer MJ, Lehnerz SD, Hebert JR, Parikh CR. Kidney disease is an independent risk factor for adverse fetal and maternal outcomes in pregnancy. Am J Kidney Dis. 2004;43(3): 415–23.
  22. Nevis IF, Reitsma A, Dominic A, McDonald S, Thabane L, Akl EA, Hladunewich M, Akbari A, Joseph G, Sia W, Iansavichus AV, Garg AX. Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol. 2011;6(11):2587–98.
  23. Piccoli GB, Fassio F, Attini R, Parisi S, Biolcati M, Ferraresi M, Pagano A, Daidola G, Deagostini MC, Gaglioti P, Todros T. Pregnancy in CKD: whom should we follow and why? Nephrol Dial Transplant. 2012;27 Suppl 3:iii111–8.
  24. Trevisan G, Ramos JG, Martins-Costa S, Barros EJ. Pregnancy in patients with chronic renal insufficiency at Hospital de Clinicas of Porto Alegre, Brazil. Ren Fail. 2004;26(1):29–34.
  25. Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008;336(7637):211–5.
  26. Савельева ГМ. Справочник по акушерству, гинекологии и перинатологии. М.: МИА; 2006. 720 с. (Savel'eva GM. A guide on obstetrics, gynaecology and perinatology. Moscow: MIA; 2006.720 p. Russian).
  27. Логутова ЛС, ред. Экстрагенитальная патология и беременность: практическое руководство. М.: Литтерра; 2012. (Logutova LS, editor. Extragenital disorders and pregnancy: a practical guide. Moscow: Litterra; 2012. Russian).
  28. Sergio F, Maria Clara D, Gabriella F, Giorgia S, Sara De Carolis, Giancarlo P, Alessandro C. Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus lowdose aspirin versus low-dose aspirin alone. Hypertens Pregnancy. 2006;25(2):115–27.
  29. Гайтон АК, Холл ДЭ. Медицинская физиология. Пер. с англ. М.: Логосфера; 2008. 1296 p. (Guyton AK, Hall DE. Medical physiology. Moscow: Logosfera; 2008. 1296 p. Russian).
  30. Гомазков ОА. Молекулярные и физиологические аспекты эндотелиальной дисфункции. Роль эндогенных химических регуляторов. Успехи физиологических наук. 2004;31(4):48–62. (Gomazkov OA. [Molecular and physiologic aspects of endothelial dysfunction.The role of endogenous chemical mediators]. Uspekhi fiziologicheskikh nauk. 2004;31(4):48–62. Russian).
  31. Смирнов АВ, Жлоба АА, Барабанова ВВ, Чефу СГ, Береснева ОН, Сиповский ВГ, Добронравов ВА. Гипергомоцистеинемия как фактор повреждения почек. Нефрология. 2004;8(Прилож. 2):284. (Smirnov AV, Zhloba AA, Barabanova VV, Chefu SG, Beresneva ON, Sipovskiy VG, Dobronravov VA. [Hyperhomocysteinemia as a risk factor for obstetric complications]. Nefrologiya. 2004;8(Suppl 2):284. Russian).
  32. Nurk E, Tell GS, Refsum H, Ueland PM, Vollset SE. Factor V Leiden, pregnancy complications and adverse outcomes: the Hordaland Homocysteine Study. QJM. 2006;99(5):289–98.
  33. Owen EP, Human L, Carolissen AA, Harley EH, Odendaal HJ. Hyperhomocysteinemia – a risk factor for abruptio placentae. J Inherit Metab Dis. 1997;20(3):359–62.
  34. Боброва ЛА. Поражение почек при наследственных и приобретенных тромбофилиях: Автореф. дис. … канд. мед. наук. М.; 2010. 24 с. (Bobrova LA. Renal damage in hereditary and acquired thrombophilias. Abstract of the dissertation on the degree of candidate of medical sciences. Moscow; 2010. 24 p. Russian).
  35. Knight M, Duley L, Henderson-Smart DJ, King JF. WITHDRAWN: Antiplatelet agents for preventing and treating preeclampsia.
  36. Cochrane Database Syst Rev. 2007;(2):CD000492.
  37. Gris JC, Chauleur C, Molinari N, Mares P, Fabbro-Peray P, Quere I, Lefrant JY, Haddad B, Dauzat M. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomized controlled NOH-PE trial. Thromb Haemost. 2011;106(6):1053–61.
  38. Urban G, Vergani P, Tironi R, Ceruti P, Vertemati E, Sala F, Pogliani E, Triche EW, Lockwood CJ, Paidas MJ. Antithrombotic prophylaxis in multiparous women with preeclampsia or intrauterine growth retardation in an antecedent pregnancy. Int J Fertil Womens Med. 2007;52(2–3):59–67.
  39. Guler T, Polat ZA, Yayci E, Atacag T, Cetin A. Effects of low molecular weight heparins and unfractionated heparin on viability of human umbilical vein endothelial cells. Arch Gynecol Obstet. 2013;287(2):217–22.
  40. Sobel ML, Kingdom J, Drewlo S. Angiogenic response of placental villi to heparin. Obstet Gynecol. 2011;117(6):1375–83.
  41. Fischer MJ. Chronic kidney disease and pregnancy: maternal and fetal outcomes. Adv Chronic Kidney Dis. 2007;14(2):132–45.
  42. Vikse BE, Irgens LM, Leivestad T, Skjaerven R, Iversen BM. Preeclampsia and the risk of end-stage renal disease. N Engl J Med. 2008;359(8):800–9.
  43. Мондоева СС, Суханова ГА, Подзолкова НМ, Левина АА, Васильев СА. Влияние гипергомоцистеинемии на репродуктивные потери и ее коррекция во время беременности. Гематология и трансфузиология. 2009;54(6):34–7. (Mondoeva SS, Sukhanova GA, Podzolkova NM, Levina AA, Vasil'ev SA. [The influence of hyperhomocysteinemia on reproductive losses and its correction during pregnancy]. Gematologiya i transfuziologiya. 2009;54(6):34–7. Russian).
  44. Шалина РИ, Ефимов ВС, Гришин ВЛ, Москвина СП. Коррекция гемокоагуляции как способ предупреждения преэклампсии беременных. В: Тромбозы и геморрагии, ДВС-синдром. Проблемы лечения. М.; 1997. с. 167–8. (Shalina RI, Efimov VS, Grishin VL, Moskvina SP. Correction of blood coagulation as a way to prevent pre-eclampsia in pregnancy. In: Thromboses and hemorrhages, DIC syndrome. Problems of treatment. Moscow; 1997. p. 167–8. Russian).
  45. Dodd JM, McLeod A, Windrim RC, Kingdom J. Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev. 2013;7:CD006780.
  46. Fielder K, Wurfel W. Effectivity of heparin in assisted reproduction. Kidney Int Suppl. 2012;2(1):1–126.
  47. Mackenzie R, Walker M, Armson A, Hannah ME. Progesterone for the prevention of preterm birth among women at increased risk: a systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol. 2006;194(5):1234–42.
  48. Никольская ИГ, Будыкина ТС, Бочарова ИИ, Новикова СВ, Ефанов АА, Ширман ЛИ, Крупская МС. Бактериурия у беременных с хронической болезнью почек и осложнения в перинатальном периоде. Российский вестник акушера-гинеколога. 2014;14(1): 44–50. (Nikol'skaya IG, Budykina TS, Bocharova II, Novikova SV, Efanov AA, Shirman LI, Krupskaya MS. [Bacteriuriain pregnant women with chronic kidney disease and complications of the perinatal period]. Rossiyskiy vestnik akusherainekologa. 2014;14(1):44–50. Russian).
  49. Koleganova N, Piecha G, Ritz E, Becker LE, Muller A, Weckbach M, Nyengaard JR, Schirmacher P, Gross-Weissmann ML. Both high and low maternal salt intake in pregnancy alter kidney development in the offspring. Am J Physiol Renal Physiol. 2011;301(2):F344–54.
  50. Roy-Clavel E, Picard S, St-Louis J, Brochu M. Induction of intrauterine growth restriction with a low-sodium diet fed to pregnant rats. Am J Obstet Gynecol. 1999;180(3 Pt 1):608–13.
  51. Sathishkumar K, Elkins R, Yallampalli U, Yallampalli C. Protein restriction during pregnancy induces hypertension and impairs endothelium-dependent vascular function in adult female offspring. J Vasc Res. 2009;46(3):229–39.
  52. Woods LL, Weeks DA, Rasch R. Programming of adult blood pressure by maternal protein restriction: role of nephrogenesis. Kidney Int. 2004;65(4):1339–48.
  53. Европейские рекомендации по оптимальной практике гемодиализа (часть 1). Нефрология и диализ. 2005;(Прилож.):65–74. (European Best Practice Guidelines for Haemodialysis (Part 1). Nefrologiya i dializ. 2005; (Suppl):65–74. Russian).
  54. Даугирдас ДжТ, Блейк ПДж, Инг ТС, ред. Руководство по диализу. Пер. с англ. 3-е изд. Тверь: Триада; 2003. 744 c. (Daugirdas JT, Blake PG, Ing TS, editors. Handbook of dialysis. 3rd ed. Tver': Triada; 2003. 744 p. Russian).
  55. Хатшуков АХ, Османов АХ, Мамхегова ТР. Ведение беременности у пациенток на гемодиализе. Нефрология и диализ.
  56. ;7(2):177–80. (Khatshukov AKh, Osmanov AKh, Mamkhegova TR. [Management of pregnancy in patients on hemodialisys]. Nefrologiya i dializ. 2005;7(2):177–80. Russian).
  57. Cornelis T, Odutayo A, Keunen J, Hladunewich M. The kidney in normal pregnancy and preeclampsia. Semin Nephrol. 2011;31(1): 4–14.
  58. Dogan OT, Polat ZA, Karahan O, Epozturk K, Altun A, Akkurt I, Cetin A. Antiangiogenic activities of bemiparin sodium, enoxaparin sodium, nadroparin calcium and tinzaparin sodium. Thromb Res. 2011;128(4):e29–32.
  59. Sanchez-Ferrer CF. Bemiparin: pharmacological profile. Drugs. 2010;70 Suppl 2:19–23.
  60. Белобородова ЕВ, Баймурадова СМ. Гипергомоцистеинемия как фактор риска развития акушерских осложнений. В: Материалы VI Российского форума «Мать и дитя»; Москва, 12–15 октября 2004 г. М.; 2004. с. 26–8. (Beloborodova EV, Baymuradova SM. Hyperhomocysteinemia as a factor of kidney damage. In: Proceedings of 6th Russian Forum “Mother and Child”; Moscow, 2004 Oct 12–15. Moscow; 2004. p. 26–8. Russian).
  61. Добронравов ВА, Жлоба АА, Трофименко ИИ. Гипергомоцистеинемия как системная проблема с точки зрения нефролога. Нефрология. 2006;10(2):7–15. (Dobronravov VA, Zhloba AA, Trofimenko II. [Hyperhomocysteinemia as a systemic problem from a nephrologist’s point of view]. Nefrologiya. 2006;10(2):7–15. Russian).
  62. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001;107(6):675–83.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Nikol'skaya I.G., Prokopenko E.I., Novikova S.V., Budykina T.S., Kokarovtseva S.N., Yakubina A.A., Krupskaya M.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies